Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.

Lustig, Robert H; Hinds, Pamela S; Ringwald-Smith, Karen; Christensen, Robbin K; Kaste, Sue C; Schreiber, Randi E; Rai, Shesh N; Lensing, Shelly Y; Wu, Shengjie; Xiong, Xiaoping

Lustig, Robert H; Hinds, Pamela S; Ringwald-Smith, Karen; Christensen, Robbin K; Kaste, Sue C; Schreiber, Randi E; Rai, Shesh N; Lensing, Shelly Y; Wu, Shengjie; Xiong, Xiaoping.

Affiliation

Lustig RH; Department of Endocrinology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. rlustig@peds.ucsf.edu

J Clin Endocrinol Metab ; 88(6): 2586-92, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12788859

Subject(s)

Hormones/therapeutic use; Hypothalamic Diseases/complications; Obesity/drug therapy; Obesity/etiology; Octreotide/therapeutic use; Adolescent; Blood Glucose/analysis; Body Height/drug effects; Body Mass Index; Body Weight/drug effects; Child; Double-Blind Method; Energy Intake/drug effects; Female; Hormones/adverse effects; Humans; Insulin/blood; Insulin-Like Growth Factor I/metabolism; Leptin/blood; Male; Obesity/pathology; Obesity/physiopathology; Octreotide/adverse effects; Placebos; Quality of Life; Safety

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Octreotide / Hormones / Hypothalamic Diseases / Obesity Type of study: Clinical_trials Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Clin Endocrinol Metab Year: 2003 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links